Financials data is unavailable for this security.
View more
Year on year Hofseth Biocare ASA grew revenues 61.79% from 120.45m to 194.87m while net income improved from a loss of 137.39m to a smaller loss of 106.68m.
Gross margin | 28.62% |
---|---|
Net profit margin | -54.66% |
Operating margin | -50.61% |
Return on assets | -30.43% |
---|---|
Return on equity | -94.82% |
Return on investment | -55.35% |
More ▼
Cash flow in NOKView more
In 2023, cash reserves at Hofseth Biocare ASA fell by 8.54m. Cash Flow from Financing totalled 3.69m or 1.90% of revenues. In addition the company generated 2.76m in cash from operations while cash used for investing totalled 14.99m.
Cash flow per share | -0.2063 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.3363 |
---|---|
Tangible book value per share | 0.225 |
More ▼
Balance sheet in NOKView more
Current ratio | 0.8734 |
---|---|
Quick ratio | 0.4075 |
Total debt/total equity | 1.23 |
---|---|
Total debt/total capital | 0.552 |
More ▼